Our team has extensive experience in oncology product development and commercialization in the North America, Europe and China.
Specifically, we are looking for:
- Marketed oncology therapeutics and supportive care products
- Innovative, patented oncology therapeutics currently in mid- or late-stage clinical trials
- Targeted therapies that enable selection of patients who are most likely to benefit
- Early-stage product candidates that may offer benefits over current products or competing product candidates
- Therapies that address solid and/or liquid tumors, including small molecules, antibodies and protein therapeutics
- Targets that have demonstrated proof of concept and molecules with defined mechanisms of action
We are also interested in:
- Potential opportunities to out-license our products for distribution in geographies outside our areas of focus
We are currently not pursuing opportunities in medical devices, off-patent or generic products, stem cell therapies or cell-based products.